XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in XBiotech Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +7 vs. Q4 2023
- Shares held
- 3.99M
- +548.0K (+15.9%) vs. Q4 2023
- Total value
- $32.5M
- +$18.7M (+135.5%) vs. Q4 2023
- New holders
- 10
- 16 more added
- Sold out
- 3
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 576 | $5 | 0.00% | +576 | New |
| JPMorgan Chase & Co | 38 | $309 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 228 | $1.00K | 0.00% | −398−63.6% | Reduced |
| Royal Bank of Canada | 99 | $1.00K | 0.00% | −189−65.6% | Reduced |
| Wells Fargo & Company | 155 | $1.26K | 0.00% | +3+2.0% | Added |
| Rhumbline Advisers | 753 | $6.12K | 0.00% | 00.0% | Unchanged |
| McIlrath & Eck, LLC | 753 | $6.12K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,117 | $9.08K | 0.00% | +1,065+2,048.1% | Added |
| Cubist Systematic Strategies, LLC | 5,254 | $42.7K | 0.00% | +5,254 | New |
| Citadel Advisors LLC | 7,042 | $57.3K | 0.00% | −5,232−42.6% | Reduced |
| UBS Group AG | 7,344 | $59.7K | 0.00% | −2,105−22.3% | Reduced |
| Bank of America Corp | 8,690 | $70.7K | 0.00% | −4,668−34.9% | Reduced |
| Charles Schwab Investment Management Inc | 10,477 | $85.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 10,707 | $87.0K | 0.00% | −14,733−57.9% | Reduced |
| Synovus Financial Corp | 11,796 | $95.9K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12,522 | $101.8K | 0.00% | +1,200+10.6% | Added |
| Thomasville National Bank | 13,350 | $108.5K | 0.01% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 16,177 | $132.0K | 0.00% | +16,177 | New |
| Price T Rowe Associates Inc | 17,600 | $144.0K | 0.00% | 00.0% | Unchanged |
| Y-Intercept (Hong Kong) Ltd | 18,043 | $146.7K | 0.01% | +18,043 | New |
| Two Sigma Advisers, LP | 18,433 | $149.9K | 0.00% | −5,567−23.2% | Reduced |
| FMR LLC | 19,966 | $162.3K | 0.00% | −74−0.4% | Reduced |
| Brevan Howard Capital Management LP | 20,578 | $167.3K | 0.02% | +20,578 | New |
| Balyasny Asset Management LLC | 21,865 | $177.8K | 0.00% | +21,865 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 25,954 | $211.0K | 0.05% | +25,954 | New |
| National Bank of Canada | 33,000 | $271.6K | 0.00% | +8,653+35.5% | Added |
| HRT Financial LP | 33,593 | $273.0K | 0.00% | +33,593 | New |
| Citigroup Inc | 36,752 | $298.8K | 0.00% | +22,013+149.4% | Added |
| Bank of New York Mellon Corp | 48,451 | $393.9K | 0.00% | −7,242−13.0% | Reduced |
| Marshall Wace, LLP | 54,679 | $444.5K | 0.00% | +54,679 | New |
| Jane Street Group, LLC | 54,822 | $445.7K | 0.00% | +38,495+235.8% | Added |
| State Street Corp | 56,526 | $459.6K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 62,161 | $505.4K | 0.00% | +62,161 | New |
| Empowered Funds, LLC | 64,277 | $522.6K | 0.01% | +4,725+7.9% | Added |
| Qube Research & Technologies Ltd | 67,662 | $550.1K | 0.00% | +11,185+19.8% | Added |
| Dimensional Fund Advisors LP | 72,475 | $589.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 75,389 | $612.9K | 0.00% | −3,638−4.6% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 77,413 | $629.4K | 0.00% | +13,468+21.1% | Added |
| Morgan Stanley | 116,327 | $945.7K | 0.00% | +5,810+5.3% | Added |
| Bridgeway Capital Management, LLC | 149,318 | $1.21M | 0.02% | +4,725+3.3% | Added |
| Susquehanna International Group, LLP | 169,812 | $1.38M | 0.00% | +132,366+353.5% | Added |
| Geode Capital Management, LLC | 195,204 | $1.59M | 0.00% | +2,616+1.4% | Added |
| Credit Suisse AG | 248,270 | $2.02M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 306,624 | $2.49M | 0.00% | +28,465+10.2% | Added |
| Vanguard Group Inc | 895,315 | $7.28M | 0.00% | +13,804+1.6% | Added |
| Millennium Management LLC | 927,368 | $7.54M | 0.01% | +131,642+16.5% | Added |
| Man Group plc | 0 | $0 | 0.00% | −58,355−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −18,922−100.0% | Sold out |
| LGT Fund Management Co Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |